I lead business development at Vincere Biosciences, a biotech developing first-in-class small molecules that rejuvenate mitochondria to treat neurodegeneration and aging-related diseases. Our platform targets mitophagy and the deubiquitinase USP30, with lead programs in Parkinson’s and peripheral indications including kidney and cardiac disease. I bridge science, AI-driven discovery, and strategic partnerships to accelerate novel therapies into the clinic.